N-NITROSOANATABINE

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

N-Nitrosoanatabine has been used as an analytical reference standard for the quantification of the analyte in urine samples using SupelMIP solid phase extraction (SPE) followed by liquid chromatography coupled to mass spectrometry (LC-MS). It may also be used as an analytical reference standard for the quantification of the analyte in human urine samples, replacement liquids of electronic cigarettes, snuff samples using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

General description

Standard for Supelco MIP SPE cartridges. For more information request Supelco Literature T407075, T706031. N-Nitrosoanatabine (NAT), classified in the third group of carcinogens, belongs to the class of tobacco-specific nitrosamines (TSNAs). TSNAs are carcinogenic compounds, formed through the burning, curing and fermentation of tobacco leaves. Their levels in tobacco can vary and significantly correlate to the amount of nitrate in tobacco. NAT is produced together with N′-nitrosonornicotine [NNN] and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [NNK]) in tobacco. It can be detected in E-cigarette cartridges, mainstream tobacco smoke, snuff, etc.